Clinical Trial

Autonomic and Peripheral Neurochemical Responses to Maximal Rowing Exercise

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to characterize autonomic, neuroendocrine, and peripheral neurochemical responses to maximal rowing exercise and early recovery in highly trained male athletes. The main questions it aims to answer are: * How do circulating concentrations of cortisol, testosterone, dopamine, serotonin, gamma-aminobutyric acid (GABA), and the testosterone-to-cortisol ratio change in response to maximal rowing exercise and during the first hour of recovery? * How do autonomic cardiovascular parameters, including heart rate variability, blood pressure variability, and baroreflex sensitivity, change 3 hours after maximal exercise compared with baseline values? * Do endocrine, peripheral neurochemical, and autonomic responses demonstrate similar or divergent recovery patterns following maximal exercise? Participants will: * Perform a maximal 6,000-m rowing ergometer test. * Undergo venous blood sampling before exercise, immediately after exercise, and 1 hour after exercise recovery for assessment of endocrine and peripheral neurochemical markers. * Undergo noninvasive cardiovascular and autonomic assessment using the Task Force Monitor System before exercise and 3 hours after exercise recovery.
Trial Details
NCT Number NCT07661953
Lead Sponsor Poznan University of Physical Education
Collaborators: Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz
Conditions Healhty
Enrollment 15 participants
Start Date 2024-06-06
Primary Completion 2024-11-25 (estimated)
Study Completion 2025-03-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-22